MiniMed IPO Priced at $20, Aims to Raise $560 Million

MiniMed Prices IPO at $20 Per Share Raising $560 Million

MiniMed Group, Inc., a subsidiary of Medtronic plc, has officially priced its initial public offering of 28 million common stock shares at $20.00 each. The offering is expected to generate gross proceeds of $560 million before deducting underwriting discounts and other expenses.

Offering Details and Ownership Structure

Shares are scheduled to begin trading on the Nasdaq Global Select Market on March 6, 2026, under the ticker symbol MMED. Following the IPO, Medtronic will maintain a significant ownership stake of approximately 90.03 percent. This figure could decrease to 88.70 percent if underwriters fully exercise their 30-day option to purchase an additional 4.2 million shares.

Use of Proceeds and Market Impact

The company plans to allocate a portion of the net proceeds for general corporate purposes. The remainder will be used to repay intercompany debt owed to Medtronic. This move solidifies MiniMed's financial standing as a separate entity while it continues its operations as a global provider of diabetes management technology.

Summary and Outlook

The market will watch the debut of MMED shares closely. The offering is expected to close on March 9, 2026, subject to customary closing conditions. A syndicate of major banks, including Goldman Sachs and BofA Securities, are serving as active bookrunners for the transaction.

FAQ

Q: What is MiniMed's IPO price and stock ticker?
A: The IPO is priced at $20.00 per share, and the stock will trade on Nasdaq under the ticker symbol "MMED".

Q: How much ownership will Medtronic retain in MiniMed?
A: Medtronic will retain approximately 90.03% ownership, or 88.70% if the underwriters' over-allotment option is exercised in full.

Source: Investing.com